Text Size

One-year results on the safety and efficacy of the InnFocus MicroShunt depending on placement and concentration of mitomycin C [Résultats à un an de l’efficacité et de l’innocuité du MicroShunt InnFocus selon l’emplacement et la concentration de MMC]

Riss I., Batlle J., Pinchuk L., Kato Y.P., Weber B.A., Parel J.-M.


  • 2015
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Pôle Ophtalmologique, Clinique Mutualiste, 46/54, avenue du Dr-Albert-Schweitzer, Pessac, 33600, France; Centro Laser, Santo Domingo, Calle Padre Fantino Falco 3, Santo Domingo, Dominica; InnFocus Inc., 12415 SW 136th Avenue #3, Miami, FL 33186, United States; Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller, 900 NW 17th Street, Miami, FL 33136, United States

Related Publications

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Inatani M., Tone Y., Ikeda T., Angeles R.


Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study

Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.


Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022